» Articles » PMID: 4876427

Dates of Onset of Relapses and the Duration of Infection in Induced Tertian Malaria with Short and Long Incubation Periods

Overview
Specialty Public Health
Date 1968 Jan 1
PMID 4876427
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The course of induced tertian malaria has been studied in patients in psychoneurological hospitals in Moscow over a long period. Various strains of P. vivax were used to infect patients; the sporozoites were transmitted by Anopheles maculipennis atroparvus bred under laboratory conditions. There are marked differences between the dates of onset of relapses, reckoned from the primary manifestations of the disease, in patients developing malaria after long and short incubation periods. P. vivax strains which have a short incubation period are characterized by producing in patients a series of relapses following a long latent period; strains with a long incubation period are characterized by the occurrence of relapses during the first 3 months after the end of the primary series of attacks. However, some P. vivax strains give rise to both types of relapse, depending on the incubation period. In any event, the duration of the disease does not, as a rule, exceed 2 years, including the incubation period. The number of mosquitos (and hence the number of sporozoites) used to infect a patient does not have any noticeable effect on the number and frequency of relapses. In short-incubation tertian malaria, the use of quinocide during the period of treatment of the primary manifestations greatly reduced the number of relapses; in long-incubation tertian malaria similarly treated with quinocide, no relapses occurred.

Citing Articles

Modeling the within-host dynamics of hypnozoite activation: An analysis of the SPf66 vaccine trial.

Mehra S, Nosten F, Luxemburger C, White N, Watson J Proc Natl Acad Sci U S A. 2024; 121(51):e2401024121.

PMID: 39656209 PMC: 11665876. DOI: 10.1073/pnas.2401024121.


The global burden of Plasmodium vivax malaria is obscure and insidious.

Battle K, Baird J PLoS Med. 2021; 18(10):e1003799.

PMID: 34618814 PMC: 8496786. DOI: 10.1371/journal.pmed.1003799.


The rise and fall of long-latency Plasmodium vivax.

White N Trans R Soc Trop Med Hyg. 2019; 113(4):163-168.

PMID: 30809676 PMC: 6432802. DOI: 10.1093/trstmh/trz002.


Experimental, therapeutic and natural transmission of Plasmodium vivax tertian malaria: scientific and anecdotal data on the history of Dutch malaria studies.

Verhave J Parasit Vectors. 2013; 6(1):19.

PMID: 23332002 PMC: 3556107. DOI: 10.1186/1756-3305-6-19.


Determinants of relapse periodicity in Plasmodium vivax malaria.

White N Malar J. 2011; 10:297.

PMID: 21989376 PMC: 3228849. DOI: 10.1186/1475-2875-10-297.


References
1.
Young M . Malaria during the last decade. Am J Trop Med Hyg. 1953; 2(3):347-59. DOI: 10.4269/ajtmh.1953.2.347. View

2.
COOPER W, COATNEY G, CULWELL W, EYLES D, Young M . Studies in human malaria. XXVI. Simultaneous infection with the Chesson and the St. Elizabeth strains of Plasmodium vivax. J Natl Malar Soc. 1950; 9(2):187-90. View

3.
Shute P, Maryon M . A contribution to the problem of strains of human plasmodium. Riv Malariol. 1954; 33(1-3):1-21. View

4.
COATNEY G, COOPER W, Young M . Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malar Soc. 1950; 9(4):381-96. View

5.
TIBURSKAIA N . [Description of strains of the causative agent of tertian malaria producing manifestations of the infection after a short incubation]. Med Parazitol (Mosk). 1965; 34(6):667-72. View